Gastroenterology
By revealing that OTUD3 limits microbiota-driven STING activation, the findings of a new study offer insights into the disease mechanisms of ulcerative colitis and may pave the way to new…
Engineered bacteria can be used in gut therapies, but maintaining control over their colonization and genetic stability remains challenging.
Calcium ions affect the growth of both L. acidophilus ATCC 4356 and L. plantarum ATCC 14917, despite some differences.
STING activity is important for gut health and that targeting this molecule could offer new treatments for IBD.
Fiber can influence how well bacteria from a fecal microbiota transplant successfully settle and grow in a person’s gut.
Region-specific microbial transplants may be safer and more effective than standard fecal microbiota transplants.
Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.
Fungal metabolites such as FF-C1 may offer a new therapeutic approach for treating MAFLD and related conditions.
Even small differences between strains of gut bacteria—often within the same species—can sway how these microbes interact with the human body and influence disease outcomes.
TCA can help to manage IBD by supporting the gut barrier and influencing microbiota composition.
